Last update 08 May 2025

Zhejiang Hesenna Pharmaceutical Co., Ltd.

Private Company|2020|Zhejiang Sheng, China|
10-50

Overview

Basic Info

Introduction
Zhejiang Hesenna Pharmaceutical Co., Ltd., established in 2020 as the main entity of the group in Lishui, Zhejiang Province, strives to serve the international market from its base in China. The company specializes in providing integrated services for the commercialization, supply chain management, and brand promotion of high-end patented medicines within China. In the field of bone health, Hesen focuses on the prevention and treatment of skeletal-related events (SREs) in cancer patients with bone metastasis and promotes comprehensive diagnosis and treatment plans for osteoporosis. Additionally, in women's health, Hesen concentrates on gynecological tumors and reproductive health.

Tags

Endocrinology and Metabolic Disease
Skin and Musculoskeletal Diseases
Other Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
FDPS(Farnesyl diphosphate synthase)1

Related

1
Drugs associated with Zhejiang Hesenna Pharmaceutical Co., Ltd.
Ibandronate Sodium
Target
FDPS
Mechanism
FDPS inhibitors
Active Org.
Atnahs Pharma Netherlands B.V. [+10]
Originator Org.
Genentech, Inc.Genentech, Inc.
Active Indication
Osteoporosis [+6]
Inactive Indication
Bone Cancer [+8]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
European Union [+3]
First Approval Date25 Jun 1996
100 Clinical Results associated with Zhejiang Hesenna Pharmaceutical Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Zhejiang Hesenna Pharmaceutical Co., Ltd.
Login to view more data
100 Deals associated with Zhejiang Hesenna Pharmaceutical Co., Ltd.
Login to view more data
100 Translational Medicine associated with Zhejiang Hesenna Pharmaceutical Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 16 Aug 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
NDA/BLA
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Ibandronate Sodium
 ( FDPS )		-
NDA/BLA
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free